Publication | Closed Access

Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer

Histone ModificationsChromatinChromatin RemodelingEpigenetic ChangeEpigenomicsAberrant Dna MethylationCancer GenomicsSystems BiologyMedicineRadiation OncologyEpigeneticsLung CancerGene Expression Profiling